{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:04:46Z","timestamp":1784009086715,"version":"3.55.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transgender individuals represent a marginalised population, often exposed to unique psychosocial stressors, limited healthcare access, and social exclusion, all of which may contribute to an increased risk of cardiovascular disease (CVD). However, evidence focusing exclusively on the cardiovascular outcomes in this group remains limited. This systematic review and meta-analysis aimed to estimate the pooled prevalence of major cardiovascular morbidities among transgender adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of five databases (PubMed, PubMed Central, Embase, Scopus, and Google Scholar) was conducted to identify observational studies reporting cardiovascular outcomes in transgender individuals aged \u226518 years. The study protocol was registered with PROSPERO (CRD42022383213). The inclusion criteria were cross-sectional, cohort, and case-control studies published in English. Data extraction and quality assessment were independently performed by two reviewers using standardised tools. A meta-analysis was conducted using a random-effects model, and publication bias was assessed using funnel plots and Egger's test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      10 eligible studies that focused on transgender individuals were included in the final analysis. The pooled prevalence rates were hypertension 21% (95% CI: 12\u201336;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 99.0%), stroke\/CVA 5% (95% CI: 3\u20138;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 84.3%), coronary artery disease (CAD) 3% (95% CI: 1\u201319;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 98.8%), and myocardial infarction (MI) 7% (95% CI: 6\u20139;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 75.5%). Funnel plots indicated a symmetrical distribution for hypertension and stroke, suggesting low publication bias, whereas asymmetry was noted for CAD and MI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review revealed a substantial burden of cardiovascular morbidity among transgender individuals, warranting routine screening and targeted preventive strategies in this population. Policymakers and healthcare providers should consider inclusive approaches to reduce cardiovascular risk. Further longitudinal studies and comparative analyses of cisgender populations are essential for guiding evidence-based interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42022383213<\/jats:ext-link>\n                      , identifier: CRD42022383213.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1755343","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:37:20Z","timestamp":1784007440000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mapping the cardiovascular burden in transgender individuals: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Mallicka","family":"Mallicka","sequence":"first","affiliation":[{"name":"Department of Community Medicine, Integral University","place":["Lucknow, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deep","family":"Shikha","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University","place":["Dehradun, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Chandan","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Kalinga Institute of Industrial Technology Deemed to be University","place":["Bhubaneswar, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Government Doon Medical College","place":["Dehradun, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"B1","unstructured":"Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People"},{"key":"B2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0140-6736(16)00683-8","article-title":"Transgender people: health at the margins of society","volume":"388","author":"Winter","year":"2016","journal-title":"Lancet."},{"key":"B3","unstructured":"Transgenderism in India: insights from current census\n          \n          \n            \n              Naik\n              N\n            \n          \n          Population Association of America (PAA) 2019 Annual Meeting\n          \n          2019"},{"key":"B4","doi-asserted-by":"publisher","first-page":"102296","DOI":"10.1016\/j.bpobgyn.2022.102296","article-title":"T'Sjoen G. Gender-affirming hormonal therapy for transgender and gender-diverse people-a narrative review","volume":"86","author":"Defreyne","year":"2023","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"B5","first-page":"1","volume":"2010","author":"Grant","year":"","journal-title":"National Transgender Discrimination Survey Report on Health and Health Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.2105\/AJPH.2016.303578","article-title":"Transgender population size in the United States: a meta-regression of population-based probability samples","volume":"107","author":"Meerwijk","year":"2017","journal-title":"Am J Public Health."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1093\/cvr\/cvab288","article-title":"Cardiovascular disease in transgender people: recent research and emerging evidence","volume":"117","author":"Connelly","year":"2021","journal-title":"Cardiovasc Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/HYPERTENSIONAHA.119.13080","article-title":"Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults","volume":"74","author":"Connelly","year":"2019","journal-title":"Hypertension."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1161\/CIR.0000000000000914","article-title":"Assessing and addressing cardiovascular health in LGBTQ adults: a scientific statement from the American Heart Association","volume":"142","author":"Caceres","year":"2020","journal-title":"Circulation."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e005597","DOI":"10.1161\/CIRCOUTCOMES.119.005597","article-title":"Cardiovascular disease risk factors and myocardial infarction in the transgender population","volume":"12","author":"Alzahrani","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1161\/CIR.0000000000001003","article-title":"Assessing and addressing cardiovascular health in people who are transgender and gender diverse: a scientific statement from the American Heart Association","volume":"144","author":"Streed Jr","year":"2021","journal-title":"Circulation."},{"key":"B12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11154-018-9454-3","article-title":"Cardiovascular health in transgender people","volume":"19","author":"Irwig","year":"2018","journal-title":"Reviews in Endocrine and Metabolic Disorders."},{"key":"B13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.12669\/pjms.38.1.4375","article-title":"Health problems & barriers to healthcare services for the transgender community in Lahore, Pakistan","volume":"38","author":"Manzoor","year":"2022","journal-title":"Pak J Med Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0236177","DOI":"10.1371\/journal.pone.0236177","article-title":"Cardiovascular disease risk among transgender women living with HIV in the United States","volume":"15","author":"Gosiker","year":"2020","journal-title":"PLoS ONE."},{"key":"B16","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/healthcare9060696","article-title":"Propensity score analysis assessing the burden of non-communicable diseases among the transgender population in the United States using the behavioral risk factor surveillance system (2017\u20132019)","volume":"9","author":"Pharr","year":"2021","journal-title":"InHealthcare."},{"key":"B17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1210\/js.2017-00465","article-title":"Health and cardiometabolic disease in transgender adults in the United States: behavioral risk factor surveillance system 2015","volume":"2","author":"Nokoff","year":"2018","journal-title":"J Endocr Soc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"101907","DOI":"10.1016\/j.beem.2024.101907","article-title":"Metabolic and cardiovascular risks of hormone treatment for transgender individuals","volume":"38","author":"de Silva","year":"2024","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1253\/circrep.CR-23-0021","article-title":"Cardiovascular risk in transgender people with gender-affirming hormone treatment","volume":"5","author":"Masumori","year":"2023","journal-title":"Circ Rep."},{"key":"B20","volume-title":"Blueprint for the Provision of Comprehensive Care for Trans People and Trans Communities in Asia and the Pacific","year":"2015"},{"key":"B21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2105\/AJPH.2007.132035","article-title":"Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City","volume":"99","author":"Sanchez","year":"2009","journal-title":"Am J Public Health."},{"key":"B22","doi-asserted-by":"publisher","first-page":"20803","DOI":"10.7448\/IAS.19.3.20803","article-title":"Transgender social inclusion and equality: a pivotal path to development","volume":"19","author":"Divan","year":"2016","journal-title":"J Int AIDS Soc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0026-0495(89)90233-3","article-title":"Gooren LJ, Eklund PL. Mortality and morbidity in transsexual patients with cross-gender hormone treatment","volume":"38","author":"Asscheman","year":"1989","journal-title":"Metabolism."},{"key":"B24","doi-asserted-by":"publisher","first-page":"718200","DOI":"10.3389\/fendo.2021.718200","article-title":"Cardiovascular risk associated with gender affirming hormone therapy in transgender population","volume":"12","author":"Aranda","year":"2021","journal-title":"Front Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.4103\/jfmpc.jfmpc_1128_19","article-title":"High levels of non-communicable diseases risk factors among transgenders in Puducherry, South India","volume":"9","author":"Madhavan","year":"2020","journal-title":"J Family Med Prim Care."},{"key":"B26","first-page":"1","article-title":"Social exclusion have a negative impact on the health of the transgender","volume":"1","author":"Sridevi Sivakami","year":"2011","journal-title":"Indian Streams Res J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"762","DOI":"10.4103\/jfmpc.jfmpc_1751_22","article-title":"Epidemiology of non-communicable diseases among transgender population residing in Chennai district, Tamil Nadu","volume":"12","author":"Prasanth","year":"2023","journal-title":"J Family Med Prim Care."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1210\/jc.2017-01643","article-title":"Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis","volume":"102","author":"Maraka","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/lgbt.2014.0009","article-title":"Transgender health disparities: comparing full cohort and nested matched-pair study designs in a community health center","volume":"1","author":"Reisner","year":"2014","journal-title":"LGBT Health."},{"key":"B30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/MED.0000000000000227","article-title":"Barriers to healthcare for transgender individuals","volume":"23","author":"Safer","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"B31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.18203\/2394-6040.ijcmph20190198","article-title":"Prevalence of non-communicable disease risk factors among male to female transgenders: a cross sectional study","volume":"6","author":"Shenoy","year":"2019","journal-title":"Int J Community Med Public Health."},{"key":"B32","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.focus.2023.100096","article-title":"Cardiovascular disease risk estimation for transgender and gender-diverse patients: cross-sectional analysis of baseline data from the LITE plus cohort study","volume":"2","author":"Poteat","year":"2023","journal-title":"AJPM Focus."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1755343\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:37:22Z","timestamp":1784007442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1755343\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":32,"alternative-id":["10.3389\/fpubh.2026.1755343"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1755343","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"article-number":"1755343"}}